Brief: Hangzhou Diagens Biotechnology Enters Cooperation Framework Agreement With Zhejiang Anzhen'er Medical AI Technology
11/09/2026 11:25
BRIEF-Hangzhou Diagens Biotechnology Enters Cooperation Framework Agreement With Zhejiang Anzhen'er Medical AI Technology Sept 11 (Reuters) - Hangzhou Diagens Biotechnology Co Ltd 2526.HK:
ENTERS COOPERATION FRAMEWORK AGREEMENT WITH ZHEJIANG ANZHEN'ER MEDICAL AI TECHNOLOGY
COOPERATION TERM OF THREE YEARS FOCUSED ON MEDICAL IMAGING AI AND CLOUD SERVICES
PARTIES TO BUILD PROVINCIAL-LEVEL CAPABILITY BASE FOR DIGITAL AND INTELLIGENT IMAGING, OTHERS
Further company coverage: 2526.HK
((Reuters.Briefs@thomsonreuters.com;))